Of note, lowering the level of CD44 variant (CD44v), which can steady the system Xc–, increases insulin secretion and contributes to the amino acid transport regulated by L-type amino acid transporter LAT1 in pancreatic β cells; thus guiding a new therapeutic target in diabetes (Kobayashi et al., 2018). Here, INS is linked to diabetes mellitus.